Stay updated on Phase I Study DS-2741a in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Phase I Study DS-2741a in Atopic Dermatitis Clinical Trial page.

Latest updates to the Phase I Study DS-2741a in Atopic Dermatitis Clinical Trial page
- Check5 days agoChange DetectedNo additions or deletions were detected; the page content appears unchanged from the prior version.SummaryDifference0.4%

- Check12 days agoNo Change Detected
- Check34 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference2%

- Check41 days agoChange Detected- Removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and - added a new Revision: v3.1.0.SummaryDifference0.4%

- Check55 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the old revision label was removed. The 'Back to Top' element was also removed, which is a minor UI change.SummaryDifference0.1%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.1%

- Check70 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new content related to drug safety and various disease categories. Notably, previous location details and specific disease mentions have been removed.SummaryDifference1%

Stay in the know with updates to Phase I Study DS-2741a in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase I Study DS-2741a in Atopic Dermatitis Clinical Trial page.